Loading...
•
Mar 26, 2022
Henry Schein Q1 2022 Earnings Report
Henry Schein reported record first-quarter financial results, driven by strong performance in dental and medical sales.
Key Takeaways
Henry Schein reported record first-quarter financial results with net sales of $3.2 billion, an increase of 8.7% compared to the first quarter of 2021. GAAP diluted EPS was $1.30, compared to $1.16 in the first quarter of 2021. The company affirmed its full-year 2022 GAAP diluted EPS guidance of $4.75 to $4.91.
Total first-quarter net sales reached $3.2 billion, up 8.7% compared to Q1 2021.
GAAP diluted EPS was $1.30, compared to $1.16 in Q1 2021.
Global Dental sales increased by 2.2% compared to the prior-year period.
Global Medical sales increased by 18.3% compared to the comparable period last year.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Henry Schein affirms guidance for 2022 GAAP diluted EPS to be $4.75 to $4.91 and full year sales growth is expected to be approximately 5% to 8% over 2021.
Positive Outlook
- 2022 GAAP diluted EPS attributable to Henry Schein, Inc. is expected to be $4.75 to $4.91.
- Reflects growth of 7% to 10% compared with 2021 GAAP diluted EPS of $4.45.
- Reflects growth of 5% to 9% compared with 2021 non-GAAP diluted EPS of $4.52.
- 2022 full year sales growth is expected to be approximately 5% to 8% over 2021.
- Guidance assumes that foreign currency exchange rates will remain generally consistent with current levels and end markets will remain stable.
Challenges Ahead
- Sales growth primarily reflects the latest foreign exchange rates and a decrease in sales of COVID-19 test kits.
- Guidance does not include the impact of future share repurchases.
- Guidance does not include potential future acquisitions or restructuring expenses, if any.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...